LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

LLY

785.76

-1.21%↓

JNJ

152.76

+0.26%↑

ABBV

186.41

-0.43%↓

NVO

68.78

+2.32%↑

UNH

307.81

+1.17%↑

Search

Champions Oncology Inc

Abrir

SetorSaúde

7.15 2.44

Visão Geral

Variação de preço das ações

24h

Atual

Mín

6.73

Máximo

7.44

Indicadores-chave

By Trading Economics

Rendimento

3.8M

4.5M

Vendas

3.6M

17M

P/E

Médio do Setor

17.911

50.291

EPS

0.33

Margem de lucro

26.381

Funcionários

210

EBITDA

3.8M

4.9M

Dividendos

By Dow Jones

Próximos Ganhos

10 de set. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-23M

111M

Abertura anterior

4.71

Fecho anterior

7.15

Sentimento de Notícias

By Acuity

50%

50%

154 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Champions Oncology Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de dez. de 2024, 23:55 UTC

Ações em Alta

Stocks to Watch: Adobe, Champions Oncology, DBV Technologies

Comparação entre Pares

Variação de preço

Champions Oncology Inc Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.77 / 7.61Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Very Strong Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

154 / 380 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.